These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 36902240)

  • 1. Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines.
    Lauritano D; Mastrangelo F; D'Ovidio C; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Trimarchi M; Carinci F; Conti P
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation.
    Conti P; Ronconi G; Lauritano D; Mastrangelo F; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Carinci F; Gaudelli F; Annicchiarico C; D'Ovidio C
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.
    Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G
    Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37.
    Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S
    Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.
    Tsilioni I; Russell IJ; Stewart JM; Gleason RM; Theoharides TC
    J Pharmacol Exp Ther; 2016 Mar; 356(3):664-72. PubMed ID: 26763911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
    Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast Cell Biology at Molecular Level: a Comprehensive Review.
    Elieh Ali Komi D; Wöhrl S; Bielory L
    Clin Rev Allergy Immunol; 2020 Jun; 58(3):342-365. PubMed ID: 31828527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37.
    Trimarchi M; Lauritano D; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Calvisi V; Conti P
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of substance P on uterine mast cell cytokine release during the reproductive cycle.
    Cocchiara R; Albeggiani G; Azzolina A; Bongiovanni A; Lampiasi N; Di Blasi F; Geraci D
    J Neuroimmunol; 1995 Jul; 60(1-2):107-15. PubMed ID: 7543905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
    Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TNF in mast cell neuroinflammation and pain.
    Gu Y; Yang DK; Spinas E; Kritas SK; Saggini A; Caraffa A; Antinolfi P; Saggini R; Conti P
    J Biol Regul Homeost Agents; 2015; 29(4):787-91. PubMed ID: 26753638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells.
    Patel AB; Theoharides TC
    J Pharmacol Exp Ther; 2017 Jun; 361(3):462-471. PubMed ID: 28404689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
    Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Frydas I; Theoharides TC
    Inflamm Res; 2018 Sep; 67(9):747-755. PubMed ID: 29961151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis.
    Zhang X; Dong H; Li N; Zhang S; Sun J; Zhang S; Qian Y
    J Neuroinflammation; 2016 May; 13(1):127. PubMed ID: 27245661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of P. gingivalis and E. coli LPS on the expression of proinflammatory mediators in human mast cells and their relevance to periodontal disease.
    Palaska I; Gagari E; Theoharides TC
    J Biol Regul Homeost Agents; 2016; 30(3):655-664. PubMed ID: 27655482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of substance P and PAMP(9-20) on different excitation sites of MRGPRX2 induces differences in mast cell activation.
    Che D; Zheng Y; Hou Y; Du X; Jia T; Zhao Q; Song X; Zhou T; Geng S
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108342. PubMed ID: 34753104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37.
    Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
    Eur J Pharmacol; 2018 Jan; 818():294-299. PubMed ID: 28970014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.